Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Escherichia coli

ABSTRACT: 3rd generation cephalosporin resistant Esherichia coli from diseased dogs and cats

PROVIDER: PRJDB12460 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR335726_1.fastq.gz	Fastqsanger.gz
	DRR335726_2.fastq.gz	Fastqsanger.gz
	DRR335727_1.fastq.gz	Fastqsanger.gz
	DRR335727_2.fastq.gz	Fastqsanger.gz
	DRR335728_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 192

Similar Datasets

Project description:3rd generation cephalosporin resistant, uropathogenic E. coli WGS

| PRJNA891712 | ENA

Characterisation of proteome of a novel Escherichia coli strain exhibiting mucoviscous phenotype.

Project description:Protein expression by E. coli 26561 during the late-exponential phase of cultures under anaerobic conditions was examined. E. coli 26561 is a multidrug resistant (MDR) and shows an unusual hyper-mucoviscous phenotype. Resistance includes ESBL (CTX-M-14) and proteome was determined with and without exposure to sub-MIC concentrations of the 3rd generation cephalosporin ceftazidime. Ceftazidime exposure was at two sub-MIC levels, specifically 0.25x MIC (samples 5-7), 0.5x MIC (samples 8 - 10); samples 1-4 provided the unexposed Control. Both whole and phospho-enriched fractions for each sample were analysed. Quantification of peptides was assessed using 10-plex TMT labelling in conjunction with an Orbitrap Fusion Tribrid. Raw data produced by the Orbitrap were processed using Max Quant 1.5.4.7 using the included Andromeda search engine. Peptides were searched against our own database of E. coli 26561 proteins which was produced from a hybrid assembly of our reads obtained from MiSeq and PacBio sequencing platforms.

2018-08-22 | PXD008339 | Pride

Escherichia coli and Klebsiella pneumoniae

Project description:3rd generation cephalosporin-resistant E. coli and K. pneumonia (GASREC) Genome sequencing and assembly

| PRJNA431029 | ENA

Escherichia coli

Project description:Third generation cephalosporin resistant Escherichia coli (CREC) genome sequencing

| PRJNA862705 | ENA

Escherichia coli strain:field strain

Project description:CMY-2 producing third generation cephalosporin resistant E. coli

| PRJDB8169 | ENA

Project description:Genomic Analysis of 3rd generation cephalosporin resistant Escherichia coli from dairy cow manure

| PRJNA387025 | ENA

Urinary miRNAs contained in exosome of dogs and cats

Project description:The purpose of this study was the identification of RNAs contained in the urinary exosome (UExo) from dogs and cats. The quality of total RNA in isolated urinary exosome (UExo)-derived total RNAs obtained from the column-based method (urine 1 mL) was checked by using a Bioanalyzer, and samples from normal renal function (NR) group and kidney disease (KD) group were pooled as one sample for each group. We collected NR dogs (n = 37), KD dogs (n = 47), NR cats (n=43), and KD cats (n = 45). For the next generation sequencing, libraries were prepared according to the manufacturer’s protocols and sequenced using 50-base reads acquired by using a HiSeq 2000 platform. The December 2011 (GRCm38/mm10) mouse (Mus musculus) genome data were used as reference. As a result, we could identify the miRNA from these samples.

2018-12-10 | GSE121156 | GEO

An Outer Membrane Protein-Targeting Antibiotic Against Resistant Gram-Negative Bacterial Pathogens

Project description:There is an urgent need for novel antibiotics against carbapenem and 3rd generation cephalosporin-resistant Gram-negative pathogens, for which the last-resort antibiotics have lost most of their efficacy. We describe here a novel class of synthetic antibiotics that was inspired from natural product-derived scaffolds. The antibiotics have an unprecedented mechanism of action, which targets the main component (BamA) of the Bam folding machinery required for folding and insertion of ß-barrel proteins into the outer membrane of Gram-negative bacteria. This OMPTA (outer membrane protein-targeting antibiotic) class shows potent activity against multidrug-resistant Gram-negative ESKAPE pathogens and overcomes colistin-resistance both in vitro and in vivo. A clinical candidate has the potential to address life threatening Gram-negative infections with high unmet medical need.

2019-10-22 | PXD010174 | Pride

Project description:Extended-spectrum cephalosporin resistant Escherichia coli isolated from domestic dogs

| PRJNA671493 | ENA

Project description:WGS analysis of third-generation cephalosporin resistant Escherichia coli

| PRJNA844174 | ENA